Not logged in.png)
Share.png)
SaveShare Save Predictive Value of Serum Mac-2 Binding Protein Glycosylation Isomer for Hepatic Fibrosis in Hepatitis C Virus-Infected Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
Chen, Yun-Chu; Chang, Yu-Ping; Lee, Ji-Yuh; Chen, Chi-Yi; Kao, Wei--Yu; Lin, Chih-lin; Yang, Sheng-shun; Shih, Yu-Lueng; Peng, Cheng-yuan; Lee, Fu-jen; Tsai, Ming-chang; Huang, Shang-Chin; Su, Tung-hung; Tseng, Tai-Chung; Liu, Chun-Jen; Chen, Pei-Jer; Kao, Jia-Horng; Liu, Chen-hua Share Save Share Save Share Save Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral-Induced Cure of Hepatitis C Virus InfectionChang, Yu-Ping; Lee, Ji-Yuh; Chen, Chi-Yi; Kao, Wei-Yu; Lin, Chih-Lin; Yang, Sheng-Shun; Shih, Yu-Lueng; Peng, Cheng-Yuan; Lee, Fu-Jen; Tsai, Ming-Chang; Huang, Shang-Chin; Su, Tung-Hung; Tseng, Tai-Chung; Liu, Chun-Jen; Chen, Pei-Jer; Kao, Jia-Horng; Liu, Chen-Hua Share Save Share Save Share Save Trajectories of hepatic steatosis and incidence of cardiovascular disease over a 29-year follow-upYu, Ming-Whei; Wu, Wan-Jung; Lin, Chih-Lin; Liu, Chun-Jen; Peng, Wei-Ya; Huang, Pin-Yu; Huang, Yi-Wen; Hu, Jui-Ting; Chang, Hung-Chuen; Liou, Jyh-Ming Share Save Four weeks of off-treatment follow-up is sufficient to determine virologic responses at off-treatment week 12 in patients with hepatitis C virus infection receiving fixed-dose pangenotypic direct-acting antiviralsLiu, Chen-Hua; Chang, Yu-Ping; Lee, Ji-Yuh; Chen, Chi-Yi; Kao, Wei-Yu; Lin, Chih-Lin; Yang, Sheng-Shun; Shih, Yu-Lueng; Peng, Cheng-Yuan; Lee, Fu-Jen; Tsai, Ming-Chang; Huang, Shang-Chin; Su, Tung-Hung; Tseng, Tai-Chung; Liu, Chun-Jen; Chen, Pei-Jer; Kao, Jia-Horng Share Save Dynamic change of metabolic dysfunction-associated steatotic liver disease in patients with hepatitis C virus infection after achieving sustained virologic response with direct-acting antiviralsLiu, Chen-Hua; Chang, Yu-Ping; Fang, Yu-Jen; Cheng, Pin-Nan; Chen, Chi-Yi; Kao, Wei-Yu; Lin, Chih-Lin; Yang, Sheng-Shun; Shih, Yu-Lueng; Peng, Cheng-Yuan; Tsai, Ming-Chang; Huang, Shang-Chin; Su, Tung-Hung; Tseng, Tai-Chung; Liu, Chun-Jen; Chen, Pei-Jer; Kao, Jia-Horng Share Save An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from TaiwanYu, Ming-Lung; Tai, Chi-Ming; Mo, Lein-Ray; Kuo, Hsing-Tao; Huang, Chung-Feng; Tseng, Kuo-Chih; Lo, Ching-Chu; Bair, Ming-Jong; Wang, Szu-Jen; Huang, Jee-Fu; Yeh, Ming-Lun; Chen, Chun-Ting; Tsai, Ming-Chang; Huang, Chien-Wei; Lee, Pei-Lun; Yang, Tzeng-Hue; Huang, Yi-Hsiang; Chong, Lee-Won; Chen, Chien-Lin; Yang, Chi-Chieh; Hung, Chao-Hung; Yang, Sheng-Shun; Cheng, Pin-Nan; Hsieh, Tsai-Yuan; Hu, Jui-Ting; Wu, Wen-Chih; Cheng, Chien-Yu; Chen, Guei-Ying; Zhou, Guo-Xiong; Tsai, Wei-Lun; Kao, Chien-Neng; Lin, Chih-Lang; Wang, Chia-Chi; Lin, Ta-Ya; Lin, Chih-Lin; Su, Wei-Wen; Lee, Tzong-Hsi; Chang, Te-Sheng; Liu, Chun-Jen; Dai, Chia-Yen; Chen, Chi-Yi; Kao, Jia-Horng; Lin, Han-Chieh; Chuang, Wan-Long; Peng, Cheng-Yuan Share Save Share Save Share Save Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naive patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registryChang, Te-Sheng; Huang, Chung-Feng; Kuo, Hsing-Tao; Lo, Ching-Chu; Huang, Chien-Wei; Chong, Lee-Won; Cheng, Pin-Nan; Yeh, Ming-Lun; Peng, Cheng-Yuan; Cheng, Chien-Yu; Huang, Jee-Fu; Bair, Ming-Jong; Lin, Chih-Lang; Yang, Chi-Chieh; Wang, Szu-Jen; Hsieh, Tsai-Yuan; Lee, Tzong-Hsi; Lee, Pei-Lun; Wu, Wen-Chih; Lin, Chih-Lin; Su, Wei-Wen; Yang, Sheng-Shun; Wang, Chia-Chi; Hu, Jui-Ting; Mo, Lein-Ray; Chen, Chun-Ting; Huang, Yi-Hsiang; Chang, Chun-Chao; Huang, Chia-Sheng; Chen, Guei-Ying; Kao, Chien-Neng; Tai, Chi-Ming; Liu, Chun-Jen; Lee, Mei-Hsuan; Tsai, Pei-Chien; Dai, Chia-Yen; Kao, Jia-Horng; Lin, Han-Chieh; Chuang, Wang-Long; Chen, Chi-Yi; Tseng, Kuo-Chih; Hung, Chao-Hung; Yu, Ming-Lung Share Save Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction-associated fatty liver disease and cardiovascular diseasesCheng, Pin-Nan; Chen, Wen-Jone; Hou, Charles Jia-Yin; Lin, Chih-Lin; Chang, Ming-Ling; Wang, Chia-Chi; Chang, Wei-Ting; Wang, Chao-Yung; Lin, Chun-Yen; Hung, Chung-Lieh; Peng, Cheng-Yuan; Yu, Ming-Lung; Chao, Ting-Hsing; Huang, Jee-Fu; Huang, Yi-Hsiang; Chen, Chi-Yi; Chiang, Chern-En; Lin, Han-Chieh; Li, Yi-Heng; Lin, Tsung-Hsie; Kao, Jia-Horng; Wang, Tzung-Dau; Liu, Ping-Yen; Wu, Yen-Wen; Liu, Chun-Jen Share Save Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized TrialCheng, Pin-Nan; Liu, Chun-Jen; Chen, Chi-Yi; Tseng, Kuo-Chih; Lo, Ching-Chu; Peng, Cheng-Yuan; Lin, Chih-Lin; Chiu, Hung-Chih; Chiu, Yen-Cheng; Chen, Pei-Jer Share Save Share Save Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR StudyLiu, Chen-Hua; Sun, Hsin-Yun; Peng, Cheng-Yuan; Hsieh, Szu-Min; Yang, Sheng-Shun; Kao, Wei-Yu; Shih, Yu-Lueng; Lin, Chih-Lin; Liu, Chun-Jen; Sheng, Wang-Hui; Lo, Yi-Chun; Liu, Wen-Chun; Wu, Jo-Hsuan; Su, Tung-Hung; Tseng, Tai-Chung; Chen, Pei-Jer; Hung, Chien-Ching; Kao, Jia-Horng Share Save The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in TaiwanLin, Chih-Lin; Tai, Chi-Ming; Huang, Jee-Fu; Liu, Chun-Jen; Chen, Hui-Fen; Cheng, Pin-Nan; Chen, Chi-Yi; Peng, Cheng-Yuan; Wang, Chia-Chi; Weng, Shih-Han; Tseng, Tai-Chung; Kao, Jia-Horng Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
